COMP <GO>
TFX vs LLY // RETURN ON INVESTED CAPITAL (ROIC)
Teleflex Incorporated (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: TFX 3
— LLY 11
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LLY
LAST: $141.39 (+1.73%) • MKT CAP: $5.99B
roic
1.80%
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
roic
32.36%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TFX VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TFX | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.20% | 83.64% | -27.44 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 1.80% | 32.36% | -30.56 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.9x | 36.4x | +4.48 | LLY | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 2.30% | -20.30 | LLY | /fcf-yield <GO> |
| Operating Margin | 5.90% | 40.21% | -34.31 | LLY | /operating-margins <GO> |
| Net Profit Margin | -45.40% | 31.90% | -77.30 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 17.20% | 45.51% | -28.31 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 0.49% | +0.52 | TFX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 9.29 | -7.17 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 9/9 | -5.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.2 | 66.6 | +3.60 | TFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.51 | +0.47 | TFX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 26.3x | +0.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.99B | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TFX REV | LLY REV | TFX GROSS % | LLY GROSS % | TFX FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $65.18B | 56.2% | 83.0% | — | $16.81B |
| FY 2024 | $1.70B | $45.04B | 61.0% | 81.3% | — | $8.82B |
| FY 2023 | $1.71B | $34.12B | — | 79.3% | — | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TFX // BETA 0.98
LLY // BETA 0.51